Kypros Pharmaceuticals Private Limited
About Kypros Pharmaceuticals Private Limited
Data last updated:
Kypros Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33100PN2023PTC217497.
The company has an authorised share capital of ₹4.98 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sandeep Kumar Rathore and Ankur Mahajan.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 347/12 Ulhas Nagar Dhole Patil Road Near City Point, Pune, Maharashtra, India – 411001.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kypros Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered Address347/12 Ulhas Nagar Dhole Patil Road Near City Point, Pune, Maharashtra, India – 411001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kypros Pharmaceuticals Private Limited
FY 2025 filings availableKypros Pharmaceuticals Private Limited reported revenue of ₹1,426 (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Kypros Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kypros Pharmaceuticals Private Limited
Kypros Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar Rathore | Director | 02 Jan 2023 | 3 Years 9 Months | Current |
| Ankur Mahajan | Director | 02 Jan 2023 | 3 Years 9 Months | Current |
| Ashok Kumar | Director | 02 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Kypros Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eg Pharma Private Limited | ₹1,589 (FY 2024) | 7.0% | Punjab, India | |||
| A4 Pharma Private Limited | ₹1,567 (FY 2025) | -99.0% | Faridabad, Haryana, India | |||
| Karjee Pharmaceuticals Private Limited | ₹1,500 (FY 2024) | -99.0% | Lucknow, Uttar Pradesh, India | |||
| Aqua-Cap Software Consultancy Services Private Limited | ₹1,498 (FY 2024) | 149.0% | Bangalore, Karnataka, India | |||
| Indian Pharmaceutical Research Laboratories Private Limited | ₹1,440 (FY 2025) | 1100.0% | Mumbai, Maharashtra, India | |||
| Kypros Pharmaceuticals Private Limitedthis company | ₹1,426 (FY 2025) | -39.0% | Pune, Maharashtra, India | |||
| Sigcap Pharmaceuticals (I) Private Limited | ₹1,326 (FY 2023) | 14.0% | Kolkata, West Bengal, India | |||
| Empathy Lifesciences Private Limited | ₹1,237 (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| R R Biotec India Private Limited | ₹1,218 (FY 2024) | -93.0% | Kala Amb, Himachal Pradesh, India | |||
| Emson Medi Chem Private Limited | ₹1,218 (FY 2021) | 46.0% | Mumbai, Maharashtra, India | |||
| P and V Formulations Private Limited | ₹1,200 (FY 2025) | Rajura, Maharashtra, India |
To see the full peer comparison of Kypros Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kypros Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kypros Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kypros Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kypros Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Ankur Mahajan was appointed as Director on 02 Jan 2023.
Frequently asked questions
Kypros Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2023 (3+ years old) and is registered under CIN U33100PN2023PTC217497.
Kypros Pharmaceuticals has 3 current directors:
- Sandeep Kumar Rathore - Director
- Ankur Mahajan - Director
- Ashok Kumar - Director
The latest financial statements of Kypros Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Kypros Pharmaceuticals is U33100PN2023PTC217497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kypros Pharmaceuticals was incorporated on 02 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Kypros Pharmaceuticals by revenue are Eg Pharma Private Limited, A4 Pharma Private Limited, Karjee Pharmaceuticals Private Limited, Aqua-Cap Software Consultancy Services Private Limited, Indian Pharmaceutical Research Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Ankur Mahajan was appointed as Director on 02 Jan 2023. Ashok Kumar was appointed as Director on 02 Jan 2023. Sandeep Kumar Rathore was appointed as Director on 02 Jan 2023.
The registered office of Kypros Pharmaceuticals is at 34712 Ulhas Nagar Dhole Patil Road Near City Point, Pune, Maharashtra, India – 411001.
Kypros Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Kypros Pharmaceuticals is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Kypros Pharmaceuticals can be reached at its registered office: 34712 Ulhas Nagar Dhole Patil Road Near City Point, Pune, Maharashtra, India – 411001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
